Greenwich LifeSciences, Inc. GLSI
$18.70
+35.90%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $70.00
- Implied Upside
- +274.3%
- Price Target Range
- $70.00 – $70.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-18 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $69 → $70 |
| 2026-07-21 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $50 → $69 |
| 2025-12-30 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $39 → $50 |
| 2025-04-21 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $38 → $39 |
| 2025-02-11 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $38 |
| 2024-08-23 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $36 → $38 |
| 2024-05-22 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $36 |
| 2024-02-28 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $36 |
| 2024-02-20 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $38 → $36 |
| 2023-04-10 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $78 → $38 |
| 2021-09-01 | HC Wainwright & Co.Yi Chen |
Initiates coverage on | Buy | $78 |
| 2021-01-26 | Aegis CapitalNathan Weinstein |
Initiates coverage on | Buy | $75 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $18.70
- Market Cap
- $201.97 million
- 52-Week Range
- $7.78 – $34.10
- Average Volume
- 169K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
